Insider Trading › NKTR › Insiders
NEKTAR THERAPEUTICS
NKTR·Nasdaq·
United States·Insider activity
United States·Insider activity$39.91
-2.31 (-5.47%)
Close · Oct 6, 2026 · Close Prices from Tiingo.com
NKTR
Insider purchases and sales on the price
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
NKTRS&P 500 (rebased)
Insider BuyInsider SellForm 144 · planned sale
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
In the last 180 days, NKTR insiders filed 0 purchases ($0) and 10 sales ($2.0M) on the open market, by 2 insiders. Newest filing Aug 20, 2026 (1 month ago).
Net Insider Buying by Quarter
Shares bought (+) or sold (−) on the open market by NKTR insiders · Form 4 · last two years
On Record
$0Purchases · 180 days
$2.0MSales · 180 days
505Open-market transactions on record
2Insiders filing · 180 days
Purchases (code P) and sales (code S) of NKTR common stock reported on Form 4, with Form 5 annual catch-ups. Grants, option exercises, gifts and tax withholding are not shown. Dollars are shares × the stated price; a price outside anything the stock traded at that day is withheld (n/c).
Insider Transactions
505 on record · newest trade first · the newest 300 shown
AllPurchasesSalesOfficers & directors
| Insider | Type | Shares | Price | Value | Held after | Traded | Filed | |
|---|---|---|---|---|---|---|---|---|
| Zalevsky JonathanChief R&D Officer | Sale | −186 | $71.98 | $13K | 9,570direct | Aug 18, 2026 | Aug 20, 2026 | Form 4 ↗ |
| ROBIN HOWARD WPresident & CEO · Director | Sale | −418 | $71.98 | $30K | 54.6Kdirect | Aug 18, 2026 | Aug 20, 2026 | Form 4 ↗ |
| Zalevsky JonathanChief R&D Officer | Sale | −5,681 | $70.00 | $398K | 9,756direct | Jun 30, 2026 | Jul 2, 2026 | Form 4 ↗ |
| ROBIN HOWARD WPresident & CEO · Director | Sale | −4,500 | $61.65 | $277K | 55.0Kdirect | Jun 17, 2026 | Jun 18, 2026 | Form 4 ↗ |
| ROBIN HOWARD WPresident & CEO · Director | Sale | −5,500 | $60.81 | $334K | 59.5Kdirect | Jun 17, 2026 | Jun 18, 2026 | Form 4 ↗ |
| ROBIN HOWARD WPresident & CEO · Director | Sale | −4,697 | $60.71 | $285K | 65.0Kdirect | Jun 16, 2026 | Jun 18, 2026 | Form 4 ↗ |
| ROBIN HOWARD WPresident & CEO · Director | Sale | −5,303 | $59.97 | $318K | 69.7Kdirect | Jun 16, 2026 | Jun 18, 2026 | Form 4 ↗ |
| Zalevsky JonathanChief R&D Officer | Sale | −5,538 | $60.71 | $336K | 15.4Kdirect | Jun 15, 2026 | Jun 17, 2026 | Form 4 ↗ |
| Zalevsky JonathanChief R&D Officer | Sale | −199 | $65.51 | $13K | 21.0Kdirect | May 19, 2026 | May 21, 2026 | Form 4 ↗ |
| ROBIN HOWARD WPresident & CEO · Director | Sale | −444 | $65.51 | $29K | 75.0Kdirect | May 19, 2026 | May 21, 2026 | Form 4 ↗ |
| Zalevsky JonathanChief R&D Officer | Sale | −180 | $73.00 | $13K | 21.2Kdirect | Feb 18, 2026 | Feb 20, 2026 | Form 4 ↗ |
| ROBIN HOWARD WPresident & CEO · Director | Sale | −423 | $73.00 | $31K | 75.5Kdirect | Feb 18, 2026 | Feb 20, 2026 | Form 4 ↗ |
| Zalevsky JonathanChief R&D Officer | Sale | −3,867 | $35.67 | $138K | 21.4Kdirect | Jan 20, 2026 | Jan 22, 2026 | Form 4 ↗ |
| Zalevsky JonathanChief R&D Officer | Sale | −1,157 | n/c | — | 19.0Kdirect | Nov 25, 2025 | Nov 25, 2025 | Form 4 ↗ |
| Wilson Mark AndrewChief Legal Officer | Sale | −630 | n/c | — | 21.6Kdirect | Nov 25, 2025 | Nov 25, 2025 | Form 4 ↗ |
| ROBIN HOWARD WPresident & CEO · Director | Sale | −2,207 | n/c | — | 54.2Kdirect | Nov 25, 2025 | Nov 25, 2025 | Form 4 ↗ |
| ROBIN HOWARD WPresident & CEO · Director | Sale | −1,210 | $48.18 | $58K | 49.3Kdirect | Sep 9, 2025 | Sep 11, 2025 | Form 4 ↗ |
| ROBIN HOWARD WPresident & CEO · Director | Sale | −2,156 | $47.49 | $102K | 50.6Kdirect | Sep 9, 2025 | Sep 11, 2025 | Form 4 ↗ |
| ROBIN HOWARD WPresident & CEO · Director | Sale | −1,200 | $46.41 | $56K | 52.7Kdirect | Sep 9, 2025 | Sep 11, 2025 | Form 4 ↗ |
| ROBIN HOWARD WPresident & CEO · Director | Sale | −2,100 | $45.16 | $95K | 53.9Kdirect | Sep 9, 2025 | Sep 11, 2025 | Form 4 ↗ |
| ROBIN HOWARD WPresident & CEO · Director | Sale | −1,136 | $39.89 | $45K | 56.0Kdirect | Sep 5, 2025 | Sep 8, 2025 | Form 4 ↗ |
| ROBIN HOWARD WPresident & CEO · Director | Sale | −2,226 | $38.82 | $86K | 57.1Kdirect | Sep 5, 2025 | Sep 8, 2025 | Form 4 ↗ |
| ROBIN HOWARD WPresident & CEO · Director | Sale | −3,304 | $37.87 | $125K | 59.4Kdirect | Sep 5, 2025 | Sep 8, 2025 | Form 4 ↗ |
| Zalevsky JonathanChief R&D Officer | Sale | −307 | $35.69 | $11K | 17.5Kdirect | Sep 4, 2025 | Sep 8, 2025 | Form 4 ↗ |
| Zalevsky JonathanChief R&D Officer | Sale | −189 | $34.41 | $7K | 17.8Kdirect | Sep 4, 2025 | Sep 8, 2025 | Form 4 ↗ |
| Zalevsky JonathanChief R&D Officer | Sale | −432 | $33.60 | $15K | 18.0Kdirect | Sep 4, 2025 | Sep 8, 2025 | Form 4 ↗ |
| Zalevsky JonathanChief R&D Officer | Sale | −793 | $32.43 | $26K | 18.4Kdirect | Sep 4, 2025 | Sep 8, 2025 | Form 4 ↗ |
| ROBIN HOWARD WPresident & CEO · Director | Sale | −1,134 | $35.80 | $41K | 62.7Kdirect | Sep 4, 2025 | Sep 8, 2025 | Form 4 ↗ |
| ROBIN HOWARD WPresident & CEO · Director | Sale | −613 | $34.40 | $21K | 63.8Kdirect | Sep 4, 2025 | Sep 8, 2025 | Form 4 ↗ |
| ROBIN HOWARD WPresident & CEO · Director | Sale | −1,496 | $33.54 | $50K | 64.4Kdirect | Sep 4, 2025 | Sep 8, 2025 | Form 4 ↗ |
| ROBIN HOWARD WPresident & CEO · Director | Sale | −1,923 | $32.37 | $62K | 65.9Kdirect | Sep 4, 2025 | Sep 8, 2025 | Form 4 ↗ |
| Zalevsky JonathanChief R&D Officer | Sale | −485 | $30.10 | $15K | 19.2Kdirect | Sep 2, 2025 | Sep 4, 2025 | Form 4 ↗ |
| ROBIN HOWARD WPresident & CEO · Director | Sale | −1,500 | $30.16 | $45K | 67.8Kdirect | Sep 2, 2025 | Sep 4, 2025 | Form 4 ↗ |
| Zalevsky JonathanChief R&D Officer | Sale | −725 | $26.59 | $19K | 19.7Kdirect | Aug 19, 2025 | Aug 21, 2025 | Form 4 ↗ |
| Wilson Mark AndrewChief Legal Officer | Sale | −676 | $26.59 | $18K | 20.3Kdirect | Aug 19, 2025 | Aug 21, 2025 | Form 4 ↗ |
| ROBIN HOWARD WPresident & CEO · Director | Sale | −1,573 | $26.59 | $42K | 69.3Kdirect | Aug 19, 2025 | Aug 21, 2025 | Form 4 ↗ |
| Zalevsky JonathanChief R&D Officer | Sale | −10.7K | $0.67 | $7K | 305.9Kdirect | May 19, 2025 | May 21, 2025 | Form 4 ↗ |
| Wilson Mark AndrewChief Legal Officer | Sale | −9,996 | $0.67 | $7K | 314.3Kdirect | May 19, 2025 | May 21, 2025 | Form 4 ↗ |
| ROBIN HOWARD WPresident & CEO · Director | Sale | −23.2K | $0.67 | $16K | 1.1Mdirect | May 19, 2025 | May 21, 2025 | Form 4 ↗ |
| Zalevsky JonathanChief R&D Officer | Sale | −10.3K | $1.01 | $10K | 316.6Kdirect | Feb 19, 2025 | Feb 21, 2025 | Form 4 ↗ |
| Wilson Mark AndrewChief Legal Officer | Sale | −11.0K | $1.01 | $11K | 324.3Kdirect | Feb 19, 2025 | Feb 21, 2025 | Form 4 ↗ |
| ROBIN HOWARD WPresident & CEO · Director | Sale | −23.8K | $1.01 | $24K | 1.1Mdirect | Feb 19, 2025 | Feb 21, 2025 | Form 4 ↗ |
| Wilson Mark AndrewChief Legal Officer | Sale | −16.6K | $0.89 | $15K | 335.3Kdirect | Dec 24, 2024 | Dec 26, 2024 | Form 4 ↗ |
| Wilson Mark AndrewChief Legal Officer | Sale | −33.4K | $0.90 | $30K | 351.9Kdirect | Dec 23, 2024 | Dec 26, 2024 | Form 4 ↗ |
| Zalevsky JonathanChief R&D Officer | Sale | −51.1K | $0.94 | $48K | 326.9Kdirect | Dec 19, 2024 | Dec 20, 2024 | Form 4 ↗ |
| ROBIN HOWARD WPresident & CEO · Director | Sale | −85.0K | $0.99 | $84K | 1.1Mdirect | Dec 18, 2024 | Dec 19, 2024 | Form 4 ↗ |
| ROBIN HOWARD WPresident & CEO · Director | Sale | −47.0K | $1.01 | $47K | 1.2Mdirect | Dec 17, 2024 | Dec 19, 2024 | Form 4 ↗ |
| Zalevsky JonathanChief R&D Officer | Sale | −7,785 | $1.01 | $8K | 243.0Kdirect | Nov 19, 2024 | Nov 20, 2024 | Form 4 ↗ |
| Wilson Mark AndrewChief Legal Officer | Sale | −6,407 | $1.01 | $6K | 218.9Kdirect | Nov 19, 2024 | Nov 20, 2024 | Form 4 ↗ |
| ROBIN HOWARD WPresident & CEO · Director | Sale | −16.3K | $1.01 | $16K | 832.1Kdirect | Nov 19, 2024 | Nov 20, 2024 | Form 4 ↗ |
| Zalevsky JonathanChief R&D Officer | Sale | −6,866 | $1.28 | $9K | 250.8Kdirect | Aug 19, 2024 | Aug 20, 2024 | Form 4 ↗ |
| Wilson Mark AndrewChief Legal Officer | Sale | −5,651 | $1.28 | $7K | 225.3Kdirect | Aug 19, 2024 | Aug 20, 2024 | Form 4 ↗ |
| ROBIN HOWARD WPresident & CEO · Director | Sale | −14.9K | $1.28 | $19K | 848.4Kdirect | Aug 19, 2024 | Aug 20, 2024 | Form 4 ↗ |
| CHESS ROBERTDirector | Sale | −19.5K | $1.20 | $23K | 255.3Kdirect | Jun 14, 2024 | Jun 14, 2024 | Form 4 ↗ |
| ROBIN HOWARD WPresident & CEO · Director | Sale | −16.6K | $1.75 | $29K | 863.2Kdirect | May 17, 2024 | May 20, 2024 | Form 4 ↗ |
| Zalevsky JonathanChief R&D Officer | Sale | −7,355 | $1.75 | $13K | 257.7Kdirect | May 17, 2024 | May 20, 2024 | Form 4 ↗ |
| Wilson Mark AndrewChief Legal Officer | Sale | −6,260 | $1.75 | $11K | 230.4Kdirect | May 17, 2024 | May 20, 2024 | Form 4 ↗ |
| KROIN DAVID10% owner | Sale | −56.0K | $1.78 | $100K | 18.3Mindirect | May 10, 2024 | May 13, 2024 | Form 4 ↗ |
| Zalevsky JonathanChief R&D Officer | Sale | −9,014 | $0.68 | $6K | 265.0Kdirect | Feb 20, 2024 | Feb 22, 2024 | Form 4 ↗ |
| Wilson Mark AndrewChief Legal Officer | Sale | −7,606 | $0.68 | $5K | 236.7Kdirect | Feb 20, 2024 | Feb 22, 2024 | Form 4 ↗ |
| ROBIN HOWARD WPresident & CEO · Director | Sale | −20.0K | $0.68 | $14K | 879.9Kdirect | Feb 20, 2024 | Feb 22, 2024 | Form 4 ↗ |
| Zalevsky JonathanChief R&D Officer | Sale | −9,646 | $0.49 | $5K | 274.0Kdirect | Nov 17, 2023 | Nov 20, 2023 | Form 4 ↗ |
| Wilson Mark AndrewChief Legal Officer | Sale | −7,179 | $0.49 | $4K | 243.8Kdirect | Nov 17, 2023 | Nov 20, 2023 | Form 4 ↗ |
| ROBIN HOWARD WPresident & CEO · Director | Sale | −19.9K | $0.49 | $10K | 899.9Kdirect | Nov 17, 2023 | Nov 20, 2023 | Form 4 ↗ |
| Curet MyriamDirector | Sale | −4,359 | $0.69 | $3K | 27.4Kdirect | Sep 18, 2023 | Sep 20, 2023 | Form 4 ↗ |
| Ajer Jeffrey RobertDirector | Sale | −4,359 | $0.69 | $3K | 34.2Kdirect | Sep 18, 2023 | Sep 20, 2023 | Form 4 ↗ |
| Zalevsky JonathanChief R&D Officer | Sale | −9,703 | $0.78 | $8K | 283.7Kdirect | Aug 16, 2023 | Aug 17, 2023 | Form 4 ↗ |
| Wilson Mark AndrewChief Legal Officer | Sale | −7,221 | $0.78 | $6K | 251.0Kdirect | Aug 16, 2023 | Aug 17, 2023 | Form 4 ↗ |
| ROBIN HOWARD WPresident & CEO · Director | Sale | −20.0K | $0.78 | $16K | 919.8Kdirect | Aug 16, 2023 | Aug 17, 2023 | Form 4 ↗ |
| WHITFIELD ROY ADirector | Sale | −30.0K | $0.57 | $17K | 216.3Kdirect | Jun 14, 2023 | Jun 15, 2023 | Form 4 ↗ |
| Zalevsky JonathanChief R&D Officer | Sale | −9,791 | $0.72 | $7K | 293.4Kdirect | May 16, 2023 | May 17, 2023 | Form 4 ↗ |
| Wilson Mark AndrewChief Legal Officer | Sale | −7,543 | $0.72 | $5K | 257.7Kdirect | May 16, 2023 | May 17, 2023 | Form 4 ↗ |
| ROBIN HOWARD WPresident & CEO · Director | Sale | −20.4K | $0.72 | $15K | 939.8Kdirect | May 16, 2023 | May 17, 2023 | Form 4 ↗ |
| Zalevsky JonathanChief R&D Officer | Sale | −10.5K | $3.00 | $31K | 303.2Kdirect | Feb 16, 2023 | Feb 17, 2023 | Form 4 ↗ |
| Wilson Mark AndrewChief Legal Officer | Sale | −8,275 | $3.00 | $25K | 265.2Kdirect | Feb 16, 2023 | Feb 17, 2023 | Form 4 ↗ |
| Thomsen Jillian B.Chief Financial Officer | Sale | −10.3K | $3.00 | $31K | 313.5Kdirect | Feb 16, 2023 | Feb 17, 2023 | Form 4 ↗ |
| ROBIN HOWARD WPresident & CEO · Director | Sale | −19.6K | $3.00 | $59K | 960.2Kdirect | Feb 16, 2023 | Feb 17, 2023 | Form 4 ↗ |
| Zalevsky JonathanChief R&D Officer | Sale | −13.5K | $3.57 | $48K | 313.7Kdirect | Nov 16, 2022 | Nov 18, 2022 | Form 4 ↗ |
| Wilson Mark AndrewChief Legal Officer | Sale | −8,690 | $3.57 | $31K | 272.5Kdirect | Nov 16, 2022 | Nov 18, 2022 | Form 4 ↗ |
| Thomsen Jillian B.Chief Financial Officer | Sale | −11.1K | $3.57 | $40K | 323.8Kdirect | Nov 16, 2022 | Nov 18, 2022 | Form 4 ↗ |
| ROBIN HOWARD WPresident & CEO · Director | Sale | −38.0K | $3.57 | $136K | 979.8Kdirect | Nov 16, 2022 | Nov 18, 2022 | Form 4 ↗ |
| Curet MyriamDirector | Sale | −4,198 | $3.16 | $13K | 31.8Kdirect | Sep 23, 2022 | Sep 26, 2022 | Form 4 ↗ |
| Ajer Jeffrey RobertDirector | Sale | −4,198 | $3.16 | $13K | 38.5Kdirect | Sep 23, 2022 | Sep 26, 2022 | Form 4 ↗ |
| CHESS ROBERTDirector | Sale | −10.2K | n/c | — | 274.8Kdirect | Sep 22, 2022 | Sep 20, 2023 | Form 4 ↗ |
| CHESS ROBERTDirector | Sale | −5,100 | $3.19 | $16K | 228.2Kdirect | Sep 22, 2022 | Sep 26, 2022 | Form 4 ↗ |
| EASTHAM KARINDirector | Sale | −21.3K | $3.61 | $77K | 13.0Kdirect | Sep 13, 2022 | Sep 14, 2022 | Form 4 ↗ |
| Zalevsky JonathanChief R&D Officer | Sale | −73.7K | $4.65 | $343K | 327.1Kdirect | Aug 18, 2022 | Aug 19, 2022 | Form 4 ↗ |
| Zalevsky JonathanChief R&D Officer | Sale | −10.6K | $4.76 | $50K | 400.8Kdirect | Aug 16, 2022 | Aug 17, 2022 | Form 4 ↗ |
| Wilson Mark AndrewSVP & General Counsel | Sale | −3,189 | $4.76 | $15K | 281.2Kdirect | Aug 16, 2022 | Aug 17, 2022 | Form 4 ↗ |
| Thomsen Jillian B.SVP & Chief Accounting Officer | Sale | −2,006 | $4.76 | $10K | 334.9Kdirect | Aug 16, 2022 | Aug 17, 2022 | Form 4 ↗ |
| ROBIN HOWARD WPresident & CEO · Director | Sale | −13.8K | $4.76 | $65K | 1.0Mdirect | Aug 16, 2022 | Aug 17, 2022 | Form 4 ↗ |
| Zalevsky JonathanChief R&D Officer | Sale | −21.7K | $3.95 | $86K | 276.4Kdirect | May 16, 2022 | May 17, 2022 | Form 4 ↗ |
| Wilson Mark AndrewSVP & General Counsel | Sale | −3,136 | $3.95 | $12K | 117.9Kdirect | May 16, 2022 | May 17, 2022 | Form 4 ↗ |
| Thomsen Jillian B.SVP & Chief Accounting Officer | Sale | −5,841 | $3.95 | $23K | 170.4Kdirect | May 16, 2022 | May 17, 2022 | Form 4 ↗ |
| ROBIN HOWARD WPresident & CEO · Director | Sale | −36.5K | $3.95 | $144K | 620.9Kdirect | May 16, 2022 | May 17, 2022 | Form 4 ↗ |
| NORTHCOTT JOHNSVP & Chief Commercial Officer | Sale | −4,592 | $3.95 | $18K | 223.2Kdirect | May 16, 2022 | May 17, 2022 | Form 4 ↗ |
| Labrucherie Gil MSVP, COO & CFO | Sale | −17.4K | $3.95 | $69K | 312.9Kdirect | May 16, 2022 | May 17, 2022 | Form 4 ↗ |
| Zalevsky JonathanChief R&D Officer | Sale | −10.9K | $10.95 | $119K | 274.1Kdirect | Feb 16, 2022 | Feb 18, 2022 | Form 4 ↗ |
| Wilson Mark AndrewSVP & General Counsel | Sale | −3,661 | $10.95 | $40K | 121.1Kdirect | Feb 16, 2022 | Feb 18, 2022 | Form 4 ↗ |
| Thomsen Jillian B.SVP & Chief Accounting Officer | Sale | −2,363 | $10.95 | $26K | 165.3Kdirect | Feb 16, 2022 | Feb 18, 2022 | Form 4 ↗ |
| ROBIN HOWARD WPresident & CEO · Director | Sale | −12.5K | $10.95 | $137K | 589.0Kdirect | Feb 16, 2022 | Feb 18, 2022 | Form 4 ↗ |
| NORTHCOTT JOHNSVP & Chief Commercial Officer | Sale | −4,852 | $10.95 | $53K | 227.8Kdirect | Feb 16, 2022 | Feb 18, 2022 | Form 4 ↗ |
| Labrucherie Gil MSVP, COO & CFO | Sale | −7,579 | $10.95 | $83K | 301.6Kdirect | Feb 16, 2022 | Feb 18, 2022 | Form 4 ↗ |
| Labrucherie Gil MSVP, COO & CFO | Sale | −3,000 | $12.69 | $38K | 256.7Kdirect | Nov 18, 2021 | Nov 18, 2021 | Form 4 ↗ |
| Labrucherie Gil MSVP, COO & CFO | Sale | −21.1K | $13.16 | $278K | 259.7Kdirect | Nov 16, 2021 | Nov 18, 2021 | Form 4 ↗ |
| Zalevsky JonathanChief R&D Officer | Sale | −20.9K | $13.16 | $275K | 232.1Kdirect | Nov 16, 2021 | Nov 17, 2021 | Form 4 ↗ |
| Wilson Mark AndrewSVP & General Counsel | Sale | −6,564 | $13.16 | $86K | 86.4Kdirect | Nov 16, 2021 | Nov 17, 2021 | Form 4 ↗ |
| Thomsen Jillian B.SVP & Chief Accounting Officer | Sale | −6,741 | $13.16 | $89K | 146.0Kdirect | Nov 16, 2021 | Nov 17, 2021 | Form 4 ↗ |
| ROBIN HOWARD WPresident & CEO · Director | Sale | −42.8K | $13.16 | $563K | 475.4Kdirect | Nov 16, 2021 | Nov 17, 2021 | Form 4 ↗ |
| NORTHCOTT JOHNSVP & Chief Commercial Officer | Sale | −6,061 | $13.16 | $80K | 194.9Kdirect | Nov 16, 2021 | Nov 17, 2021 | Form 4 ↗ |
| Curet MyriamDirector | Sale | −3,665 | $17.78 | $65K | 25.8Kdirect | Sep 22, 2021 | Sep 24, 2021 | Form 4 ↗ |
| CHESS ROBERTDirector | Sale | −4,600 | $17.94 | $83K | 279.9Kdirect | Sep 22, 2021 | Sep 24, 2021 | Form 4 ↗ |
| Ajer Jeffrey RobertDirector | Sale | −3,665 | $17.78 | $65K | 32.5Kdirect | Sep 22, 2021 | Sep 24, 2021 | Form 4 ↗ |
| CHESS ROBERTDirector | Sale | −10.3K | $16.02 | $165K | 274.3Kdirect | Sep 9, 2021 | Sep 10, 2021 | Form 4 ↗ |
| CHESS ROBERTDirector | Sale | −8,000 | $16.00 | $128K | 274.3Kdirect | Sep 8, 2021 | Sep 10, 2021 | Form 4 ↗ |
| Labrucherie Gil MSVP, COO & CFO | Sale | −3,000 | $13.56 | $41K | 240.2Kdirect | Aug 17, 2021 | Aug 18, 2021 | Form 4 ↗ |
| Zalevsky JonathanChief R&D Officer | Sale | −7,662 | $13.83 | $106K | 212.8Kdirect | Aug 16, 2021 | Aug 18, 2021 | Form 4 ↗ |
| Wilson Mark AndrewSVP & General Counsel | Sale | −1,910 | $13.83 | $26K | 72.9Kdirect | Aug 16, 2021 | Aug 18, 2021 | Form 4 ↗ |
| ROBIN HOWARD WPresident & CEO · Director | Sale | −11.5K | $13.83 | $159K | 424.1Kdirect | Aug 16, 2021 | Aug 18, 2021 | Form 4 ↗ |
| Thomsen Jillian B.SVP & Chief Accounting Officer | Sale | −13.3K | $13.83 | $184K | 137.8Kdirect | Aug 16, 2021 | Aug 18, 2021 | Form 4 ↗ |
| NORTHCOTT JOHNSVP & Chief Commercial Officer | Sale | −6,192 | $13.83 | $86K | 200.9Kdirect | Aug 16, 2021 | Aug 18, 2021 | Form 4 ↗ |
| Labrucherie Gil MSVP, COO & CFO | Sale | −7,867 | $13.83 | $109K | 243.2Kdirect | Aug 16, 2021 | Aug 18, 2021 | Form 4 ↗ |
| CHESS ROBERTDirector | Sale | −91 | $16.80 | $2K | 280.6Kdirect | Jul 22, 2021 | Jul 22, 2021 | Form 4 ↗ |
| CHESS ROBERTDirector | Sale | −3,524 | $16.81 | $59K | 280.6Kdirect | Jul 21, 2021 | Jul 22, 2021 | Form 4 ↗ |
| CHESS ROBERTDirector | Sale | −2,106 | $16.80 | $35K | 280.6Kdirect | Jul 20, 2021 | Jul 22, 2021 | Form 4 ↗ |
| Zalevsky JonathanChief R&D Officer | Sale | −31.1K | $18.30 | $569K | 235.1Kdirect | May 17, 2021 | May 19, 2021 | Form 4 ↗ |
| Wilson Mark AndrewSVP & General Counsel | Sale | −1,917 | $18.30 | $35K | 74.8Kdirect | May 17, 2021 | May 19, 2021 | Form 4 ↗ |
| Thomsen Jillian B.SVP & Chief Accounting Officer | Sale | −13.4K | $18.30 | $245K | 151.2Kdirect | May 17, 2021 | May 19, 2021 | Form 4 ↗ |
| ROBIN HOWARD WPresident & CEO · Director | Sale | −11.6K | $18.30 | $212K | 435.6Kdirect | May 17, 2021 | May 19, 2021 | Form 4 ↗ |
| NORTHCOTT JOHNSVP & Chief Commercial Officer | Sale | −6,085 | $18.30 | $111K | 207.1Kdirect | May 17, 2021 | May 19, 2021 | Form 4 ↗ |
| Labrucherie Gil MSVP, COO & CFO | Sale | −7,898 | $18.30 | $145K | 251.1Kdirect | May 17, 2021 | May 19, 2021 | Form 4 ↗ |
| CHESS ROBERTDirector | Sale | −8,000 | $19.34 | $155K | 280.6Kdirect | May 12, 2021 | May 14, 2021 | Form 4 ↗ |
| CHESS ROBERTDirector | Sale | −8,000 | $18.98 | $152K | 280.6Kdirect | Apr 14, 2021 | Apr 16, 2021 | Form 4 ↗ |
| Zalevsky JonathanChief R&D Officer | Sale | −24.1K | $22.37 | $540K | 266.2Kdirect | Feb 16, 2021 | Feb 18, 2021 | Form 4 ↗ |
| Wilson Mark AndrewSVP & General Counsel | Sale | −2,173 | $22.37 | $49K | 76.7Kdirect | Feb 16, 2021 | Feb 18, 2021 | Form 4 ↗ |
| Thomsen Jillian B.SVP & Chief Accounting Officer | Sale | −11.7K | $22.37 | $262K | 164.6Kdirect | Feb 16, 2021 | Feb 18, 2021 | Form 4 ↗ |
| ROBIN HOWARD WPresident & CEO · Director | Sale | −11.5K | $22.37 | $257K | 447.2Kdirect | Feb 16, 2021 | Feb 18, 2021 | Form 4 ↗ |
| NORTHCOTT JOHNSVP & Chief Commercial Officer | Sale | −15.4K | $22.37 | $344K | 213.2Kdirect | Feb 16, 2021 | Feb 18, 2021 | Form 4 ↗ |
| Labrucherie Gil MSVP, COO & CFO | Sale | −7,977 | $22.37 | $178K | 259.0Kdirect | Feb 16, 2021 | Feb 18, 2021 | Form 4 ↗ |
| ROBIN HOWARD WPresident & CEO · Director | Sale | −58.1K | $20.58 | $1.2M | 458.7Kdirect | Feb 4, 2021 | Feb 4, 2021 | Form 4 ↗ |
| ROBIN HOWARD WPresident & CEO · Director | Sale | −91.9K | $20.10 | $1.8M | 516.8Kdirect | Feb 4, 2021 | Feb 4, 2021 | Form 4 ↗ |
| Labrucherie Gil MSVP, COO & CFO | Sale | −50.0K | $19.81 | $990K | 267.0Kdirect | Feb 4, 2021 | Feb 4, 2021 | Form 4 ↗ |
| Wilson Mark AndrewSVP & General Counsel | Sale | −5,344 | $19.45 | $104K | 78.9Kdirect | Feb 3, 2021 | Feb 4, 2021 | Form 4 ↗ |
| ROBIN HOWARD WPresident & CEO · Director | Sale | −150.0K | $19.72 | $3.0M | 458.7Kdirect | Feb 3, 2021 | Feb 4, 2021 | Form 4 ↗ |
| Labrucherie Gil MSVP, COO & CFO | Sale | −50.0K | $19.61 | $981K | 267.0Kdirect | Feb 3, 2021 | Feb 4, 2021 | Form 4 ↗ |
| ROBIN HOWARD WPresident & CEO · Director | Sale | −600 | $21.59 | $13K | 458.7Kdirect | Feb 2, 2021 | Feb 4, 2021 | Form 4 ↗ |
| ROBIN HOWARD WPresident & CEO · Director | Sale | −9,900 | $20.84 | $206K | 459.3Kdirect | Feb 2, 2021 | Feb 4, 2021 | Form 4 ↗ |
| ROBIN HOWARD WPresident & CEO · Director | Sale | −139.5K | $19.69 | $2.7M | 469.2Kdirect | Feb 2, 2021 | Feb 4, 2021 | Form 4 ↗ |
| Labrucherie Gil MSVP, COO & CFO | Sale | −1,933 | $21.66 | $42K | 267.0Kdirect | Feb 2, 2021 | Feb 4, 2021 | Form 4 ↗ |
| Labrucherie Gil MSVP, COO & CFO | Sale | −6,932 | $20.96 | $145K | 268.9Kdirect | Feb 2, 2021 | Feb 4, 2021 | Form 4 ↗ |
| Labrucherie Gil MSVP, COO & CFO | Sale | −41.1K | $19.97 | $821K | 275.8Kdirect | Feb 2, 2021 | Feb 4, 2021 | Form 4 ↗ |
| Thomsen Jillian B.SVP & Chief Accounting Officer | Sale | −75.0K | $18.62 | $1.4M | 176.3Kdirect | Jan 28, 2021 | Jan 29, 2021 | Form 4 ↗ |
| Myriam CuretDirector | Sale | −1,560 | $17.82 | $28K | 19.2Kdirect | Dec 15, 2020 | Dec 17, 2020 | Form 4 ↗ |
| Zalevsky JonathanChief R&D Officer | Sale | −16.4K | $16.40 | $269K | 250.3Kdirect | Nov 23, 2020 | Nov 25, 2020 | Form 4 ↗ |
| Zalevsky JonathanChief R&D Officer | Sale | −29.6K | $16.93 | $501K | 266.7Kdirect | Nov 16, 2020 | Nov 18, 2020 | Form 4 ↗ |
| Wilson Mark AndrewSVP & General Counsel | Sale | −1,539 | $16.93 | $26K | 49.9Kdirect | Nov 16, 2020 | Nov 18, 2020 | Form 4 ↗ |
| Thomsen Jillian B.SVP & Chief Accounting Officer | Sale | −12.0K | $16.93 | $203K | 159.8Kdirect | Nov 16, 2020 | Nov 18, 2020 | Form 4 ↗ |
| ROBIN HOWARD WPresident & CEO · Director | Sale | −12.0K | $16.93 | $203K | 352.0Kdirect | Nov 16, 2020 | Nov 18, 2020 | Form 4 ↗ |
| Labrucherie Gil MSVP, COO & CFO | Sale | −8,276 | $16.93 | $140K | 227.0Kdirect | Nov 16, 2020 | Nov 18, 2020 | Form 4 ↗ |
| Ajer Jeffrey RobertDirector | Sale | −3,250 | $17.25 | $56K | 26.0Kdirect | Sep 28, 2020 | Sep 30, 2020 | Form 4 ↗ |
| CHESS ROBERTDirector | Sale | −5,500 | $17.75 | $98K | 280.6Kdirect | Sep 25, 2020 | Sep 25, 2020 | Form 4 ↗ |
| Ajer Jeffrey RobertDirector | Sale | −2,250 | $19.74 | $44K | 20.1Kdirect | Sep 21, 2020 | Sep 21, 2020 | Form 4 ↗ |
| Labrucherie Gil MSVP, COO & CFO | Sale | −2,000 | $19.96 | $40K | 235.2Kdirect | Sep 17, 2020 | Sep 21, 2020 | Form 4 ↗ |
| CHESS ROBERTDirector | Sale | −8,000 | $18.53 | $148K | 277.0Kdirect | Sep 8, 2020 | Sep 10, 2020 | Form 4 ↗ |
| Labrucherie Gil MSVP, COO & CFO | Sale | −2,000 | $19.68 | $39K | 237.2Kdirect | Aug 18, 2020 | Aug 19, 2020 | Form 4 ↗ |
| Zalevsky JonathanChief R&D Officer | Sale | −26.2K | $19.67 | $515K | 296.3Kdirect | Aug 17, 2020 | Aug 19, 2020 | Form 4 ↗ |
| Wilson Mark AndrewSVP & General Counsel | Sale | −1,529 | $19.67 | $30K | 51.4Kdirect | Aug 17, 2020 | Aug 19, 2020 | Form 4 ↗ |
| Thomsen Jillian B.SVP & Chief Accounting Officer | Sale | −1,367 | $19.67 | $27K | 171.7Kdirect | Aug 17, 2020 | Aug 19, 2020 | Form 4 ↗ |
| ROBIN HOWARD WPresident & CEO · Director | Sale | −11.9K | $19.67 | $234K | 364.0Kdirect | Aug 17, 2020 | Aug 19, 2020 | Form 4 ↗ |
| Labrucherie Gil MSVP, COO & CFO | Sale | −6,245 | $19.67 | $123K | 239.2Kdirect | Aug 17, 2020 | Aug 19, 2020 | Form 4 ↗ |
| GREER R SCOTTDirector | Sale | −15.0K | $25.00 | $375K | 176.6Kdirect | Jul 9, 2020 | Jul 10, 2020 | Form 4 ↗ |
| CHESS ROBERTDirector | Sale | −8,000 | $24.58 | $197K | 277.0Kdirect | Jul 8, 2020 | Jul 10, 2020 | Form 4 ↗ |
| Labrucherie Gil MSVP, COO & CFO | Sale | −2,000 | $22.62 | $45K | 245.5Kdirect | May 19, 2020 | May 20, 2020 | Form 4 ↗ |
| Zalevsky JonathanChief R&D Officer | Sale | −4,558 | $22.51 | $103K | 322.5Kdirect | May 18, 2020 | May 20, 2020 | Form 4 ↗ |
| Wilson Mark AndrewSVP & General Counsel | Sale | −1,529 | $22.51 | $34K | 52.4Kdirect | May 18, 2020 | May 20, 2020 | Form 4 ↗ |
| Thomsen Jillian B.SVP & Chief Accounting Officer | Sale | −1,367 | $22.51 | $31K | 172.7Kdirect | May 18, 2020 | May 20, 2020 | Form 4 ↗ |
| ROBIN HOWARD WPresident & CEO · Director | Sale | −8,968 | $22.51 | $202K | 375.9Kdirect | May 18, 2020 | May 20, 2020 | Form 4 ↗ |
| Labrucherie Gil MSVP, COO & CFO | Sale | −5,727 | $22.51 | $129K | 247.5Kdirect | May 18, 2020 | May 20, 2020 | Form 4 ↗ |
| CHESS ROBERTDirector | Sale | −197 | $19.02 | $4K | 277.0Kdirect | Apr 15, 2020 | Apr 17, 2020 | Form 4 ↗ |
| CHESS ROBERTDirector | Sale | −7,803 | $18.36 | $143K | 277.2Kdirect | Apr 15, 2020 | Apr 17, 2020 | Form 4 ↗ |
| CHESS ROBERTDirector | Sale | −1,200 | $17.41 | $21K | 277.0Kdirect | Mar 11, 2020 | Mar 13, 2020 | Form 4 ↗ |
| CHESS ROBERTDirector | Sale | −6,800 | $16.68 | $113K | 278.2Kdirect | Mar 11, 2020 | Mar 13, 2020 | Form 4 ↗ |
| Zalevsky JonathanChief R&D Officer | Sale | −4,774 | $22.35 | $107K | 327.1Kdirect | Feb 18, 2020 | Feb 20, 2020 | Form 4 ↗ |
| Thomsen Jillian B.SVP & Chief Accounting Officer | Sale | −1,394 | $22.35 | $31K | 174.1Kdirect | Feb 18, 2020 | Feb 20, 2020 | Form 4 ↗ |
| ROBIN HOWARD WPresident & CEO · Director | Sale | −8,448 | $22.35 | $189K | 384.9Kdirect | Feb 18, 2020 | Feb 20, 2020 | Form 4 ↗ |
| Labrucherie Gil MSVP, COO & CFO | Sale | −5,938 | $22.35 | $133K | 253.2Kdirect | Feb 18, 2020 | Feb 20, 2020 | Form 4 ↗ |
| CHESS ROBERTDirector | Sale | −3,599 | $23.72 | $85K | 277.0Kdirect | Feb 12, 2020 | Feb 14, 2020 | Form 4 ↗ |
| CHESS ROBERTDirector | Sale | −4,401 | $23.32 | $103K | 280.6Kdirect | Feb 12, 2020 | Feb 14, 2020 | Form 4 ↗ |
| Thomsen Jillian B.SVP & Chief Accounting Officer | Sale | −37.5K | $22.78 | $854K | 175.5Kdirect | Feb 6, 2020 | Feb 7, 2020 | Form 4 ↗ |
| Zalevsky JonathanChief R&D Officer | Sale | −3,960 | $17.97 | $71K | 291.7Kdirect | Nov 18, 2019 | Nov 20, 2019 | Form 4 ↗ |
| Thomsen Jillian B.SVP & Chief Accounting Officer | Sale | −2,713 | $17.97 | $49K | 160.4Kdirect | Nov 18, 2019 | Nov 20, 2019 | Form 4 ↗ |
| ROBIN HOWARD WPresident & CEO · Director | Sale | −13.6K | $17.97 | $244K | 299.2Kdirect | Nov 18, 2019 | Nov 20, 2019 | Form 4 ↗ |
| Labrucherie Gil MSVP, COO & CFO | Sale | −8,863 | $17.97 | $159K | 219.0Kdirect | Nov 18, 2019 | Nov 20, 2019 | Form 4 ↗ |
| Labrucherie Gil MSVP, COO & CFO | Sale | −25.0K | $19.79 | $495K | 227.9Kdirect | Nov 13, 2019 | Nov 15, 2019 | Form 4 ↗ |
| ROBIN HOWARD WPresident & CEO · Director | Sale | −33.3K | $17.68 | $589K | 312.8Kdirect | Oct 17, 2019 | Oct 17, 2019 | Form 4 ↗ |
| ROBIN HOWARD WPresident & CEO · Director | Sale | −33.3K | $17.48 | $583K | 312.8Kdirect | Oct 16, 2019 | Oct 17, 2019 | Form 4 ↗ |
| ROBIN HOWARD WPresident & CEO · Director | Sale | −24.5K | $17.17 | $421K | 312.8Kdirect | Oct 15, 2019 | Oct 17, 2019 | Form 4 ↗ |
| ROBIN HOWARD WPresident & CEO · Director | Sale | −8,833 | $16.35 | $144K | 337.3Kdirect | Oct 15, 2019 | Oct 17, 2019 | Form 4 ↗ |
| Labrucherie Gil MSVP, COO & CFO | Sale | −25.0K | $15.83 | $396K | 227.9Kdirect | Oct 15, 2019 | Oct 17, 2019 | Form 4 ↗ |
| Ajer Jeffrey RobertDirector | Sale | −2,375 | $18.06 | $43K | 22.4Kdirect | Sep 30, 2019 | Oct 1, 2019 | Form 4 ↗ |
| Lingnau LutzDirector | Sale | −3,000 | $17.84 | $54K | 26.7Kdirect | Sep 27, 2019 | Oct 2, 2019 | Form 4 ↗ |
| CHESS ROBERTDirector | Sale | −4,000 | $17.99 | $72K | 277.0Kdirect | Sep 27, 2019 | Oct 1, 2019 | Form 4 ↗ |
| Ajer Jeffrey RobertDirector | Sale | −2,250 | $20.24 | $46K | 18.3Kdirect | Sep 20, 2019 | Sep 24, 2019 | Form 4 ↗ |
| Labrucherie Gil MSVP & Chief Financial Officer | Sale | −25.0K | $20.52 | $513K | 152.9Kdirect | Sep 16, 2019 | Sep 18, 2019 | Form 4 ↗ |
| Doberstein Stephen KSVP & Chief Scientific Officer | Purchase | +15.0K | $17.28 | $259K | 107.7Kdirect | Sep 5, 2019 | Sep 9, 2019 | Form 4 ↗ |
| Thomsen Jillian B.SVP & Chief Accounting Officer | Sale | −1,809 | $18.15 | $33K | 163.2Kdirect | Aug 16, 2019 | Aug 19, 2019 | Form 4 ↗ |
| ROBIN HOWARD WPresident & CEO · Director | Sale | −12.6K | $18.15 | $228K | 282.8Kdirect | Aug 16, 2019 | Aug 19, 2019 | Form 4 ↗ |
| Nicholson JohnSVP & Chief Operating Officer | Sale | −3,819 | $18.15 | $69K | 162.8Kdirect | Aug 16, 2019 | Aug 19, 2019 | Form 4 ↗ |
| Labrucherie Gil MSVP & Chief Financial Officer | Sale | −5,063 | $18.15 | $92K | 122.9Kdirect | Aug 16, 2019 | Aug 19, 2019 | Form 4 ↗ |
| Doberstein Stephen KSVP & Chief Scientific Officer | Sale | −3,245 | $18.15 | $59K | 92.7Kdirect | Aug 16, 2019 | Aug 19, 2019 | Form 4 ↗ |
| Labrucherie Gil MSVP & Chief Financial Officer | Sale | −25.0K | $17.79 | $445K | 127.9Kdirect | Aug 14, 2019 | Aug 16, 2019 | Form 4 ↗ |
| ROBIN HOWARD WPresident & CEO · Director | Sale | −33.3K | $29.65 | $988K | 295.3Kdirect | Jul 25, 2019 | Jul 25, 2019 | Form 4 ↗ |
| ROBIN HOWARD WPresident & CEO · Director | Sale | −33.3K | $32.11 | $1.1M | 295.3Kdirect | Jul 24, 2019 | Jul 25, 2019 | Form 4 ↗ |
| ROBIN HOWARD WPresident & CEO · Director | Sale | −33.3K | $32.10 | $1.1M | 295.3Kdirect | Jul 23, 2019 | Jul 25, 2019 | Form 4 ↗ |
| Labrucherie Gil MSVP & Chief Financial Officer | Sale | −25.0K | $34.57 | $864K | 127.9Kdirect | Jul 10, 2019 | Jul 12, 2019 | Form 4 ↗ |
| Lingnau LutzDirector | Sale | −10.0K | $34.63 | $346K | 23.2Kdirect | Jul 8, 2019 | Jul 10, 2019 | Form 4 ↗ |
| Labrucherie Gil MSVP & Chief Financial Officer | Sale | −25.0K | $33.71 | $843K | 127.9Kdirect | Jun 17, 2019 | Jun 19, 2019 | Form 4 ↗ |
| ROBIN HOWARD WPresident & CEO · Director | Sale | −33.3K | $32.69 | $1.1M | 295.3Kdirect | May 23, 2019 | May 23, 2019 | Form 4 ↗ |
| ROBIN HOWARD WPresident & CEO · Director | Sale | −33.3K | $33.38 | $1.1M | 295.3Kdirect | May 22, 2019 | May 23, 2019 | Form 4 ↗ |
| ROBIN HOWARD WPresident & CEO · Director | Sale | −33.3K | $32.93 | $1.1M | 295.3Kdirect | May 21, 2019 | May 23, 2019 | Form 4 ↗ |
| Thomsen Jillian B.SVP & Chief Accounting Officer | Sale | −1,928 | $31.37 | $60K | 164.5Kdirect | May 16, 2019 | May 17, 2019 | Form 4 ↗ |
| ROBIN HOWARD WPresident & CEO · Director | Sale | −13.4K | $31.37 | $420K | 295.3Kdirect | May 16, 2019 | May 17, 2019 | Form 4 ↗ |
| Nicholson JohnSVP & Chief Operating Officer | Sale | −4,077 | $31.37 | $128K | 166.6Kdirect | May 16, 2019 | May 17, 2019 | Form 4 ↗ |
| Labrucherie Gil MSVP & Chief Financial Officer | Sale | −3,767 | $31.37 | $118K | 127.9Kdirect | May 16, 2019 | May 17, 2019 | Form 4 ↗ |
| Hora ManinderSVP Pharma Dev & Mfg Ops | Sale | −2,449 | $31.37 | $77K | 94.7Kdirect | May 16, 2019 | May 17, 2019 | Form 4 ↗ |
| Doberstein Stephen KSVP & Chief Scientific Officer | Sale | −3,461 | $31.37 | $109K | 95.9Kdirect | May 16, 2019 | May 17, 2019 | Form 4 ↗ |
| ROBIN HOWARD WPresident & CEO · Director | Sale | −33.3K | $41.01 | $1.4M | 308.7Kdirect | Feb 21, 2019 | Feb 21, 2019 | Form 4 ↗ |
| ROBIN HOWARD WPresident & CEO · Director | Sale | −33.3K | $43.20 | $1.4M | 308.7Kdirect | Feb 20, 2019 | Feb 21, 2019 | Form 4 ↗ |
| Thomsen Jillian B.SVP & Chief Accounting Officer | Sale | −1,808 | $42.39 | $77K | 166.4Kdirect | Feb 19, 2019 | Feb 21, 2019 | Form 4 ↗ |
| ROBIN HOWARD WPresident & CEO · Director | Sale | −8,882 | $42.39 | $377K | 308.7Kdirect | Feb 19, 2019 | Feb 21, 2019 | Form 4 ↗ |
| ROBIN HOWARD WPresident & CEO · Director | Sale | −33.3K | $42.32 | $1.4M | 317.6Kdirect | Feb 19, 2019 | Feb 21, 2019 | Form 4 ↗ |
| Nicholson JohnSVP & Chief Operating Officer | Sale | −3,822 | $42.39 | $162K | 170.7Kdirect | Feb 19, 2019 | Feb 21, 2019 | Form 4 ↗ |
| Labrucherie Gil MSVP & Chief Financial Officer | Sale | −3,592 | $42.39 | $152K | 131.7Kdirect | Feb 19, 2019 | Feb 21, 2019 | Form 4 ↗ |
| Hora ManinderSVP Pharma Dev & Mfg Ops | Sale | −2,386 | $42.39 | $101K | 97.1Kdirect | Feb 19, 2019 | Feb 21, 2019 | Form 4 ↗ |
| Doberstein Stephen KSVP & Chief Scientific Officer | Sale | −3,310 | $42.39 | $140K | 99.4Kdirect | Feb 19, 2019 | Feb 21, 2019 | Form 4 ↗ |
| Thomsen Jillian B.SVP & Chief Accounting Officer | Sale | −16.1K | $42.16 | $680K | 168.2Kdirect | Feb 4, 2019 | Feb 6, 2019 | Form 4 ↗ |
| Nicholson JohnSVP & Chief Operating Officer | Sale | −63.0K | $42.82 | $2.7M | 174.5Kdirect | Jan 28, 2019 | Jan 30, 2019 | Form 4 ↗ |
| Thomsen Jillian B.SVP & Chief Accounting Officer | Sale | −4,016 | $38.25 | $154K | 157.2Kdirect | Nov 16, 2018 | Nov 19, 2018 | Form 4 ↗ |
| ROBIN HOWARD WPresident & CEO · Director | Sale | −15.3K | $38.25 | $586K | 249.1Kdirect | Nov 16, 2018 | Nov 19, 2018 | Form 4 ↗ |
| Nicholson JohnSVP & Chief Operating Officer | Sale | −5,982 | $38.25 | $229K | 174.5Kdirect | Nov 16, 2018 | Nov 19, 2018 | Form 4 ↗ |
| Labrucherie Gil MSVP & Chief Financial Officer | Sale | −6,515 | $38.25 | $249K | 106.5Kdirect | Nov 16, 2018 | Nov 19, 2018 | Form 4 ↗ |
| Hora ManinderSVP Pharma Dev & Mfg Ops | Sale | −4,694 | $38.25 | $180K | 81.0Kdirect | Nov 16, 2018 | Nov 19, 2018 | Form 4 ↗ |
| Doberstein Stephen KSVP & Chief Scientific Officer | Sale | −4,524 | $38.25 | $173K | 78.7Kdirect | Nov 16, 2018 | Nov 19, 2018 | Form 4 ↗ |
| Lingnau LutzDirector | Sale | −9,000 | $56.98 | $513K | 18.4Kdirect | Sep 20, 2018 | Sep 21, 2018 | Form 4 ↗ |
| Ajer Jeffrey RobertDirector | Sale | −6,750 | $56.76 | $383K | 15.8Kdirect | Sep 20, 2018 | Sep 21, 2018 | Form 4 ↗ |
| CHESS ROBERTDirector | Sale | −4,500 | $56.81 | $256K | 269.7Kdirect | Sep 19, 2018 | Sep 21, 2018 | Form 4 ↗ |
| GREER R SCOTTDirector | Sale | −10.0K | $67.39 | $674K | 130.3Kdirect | Sep 4, 2018 | Sep 6, 2018 | Form 4 ↗ |
| WINGER DENNIS LDirector | Sale | −15.0K | $60.30 | $905K | 42.8Kdirect | Aug 21, 2018 | Aug 21, 2018 | Form 4 ↗ |
| WINGER DENNIS LDirector | Sale | −15.0K | $59.62 | $894K | 42.8Kdirect | Aug 17, 2018 | Aug 21, 2018 | Form 4 ↗ |
| WINGER DENNIS LDirector | Sale | −17.1K | $60.15 | $1.0M | 42.8Kdirect | Aug 14, 2018 | Aug 15, 2018 | Form 4 ↗ |
| WINGER DENNIS LDirector | Sale | −17.1K | $61.04 | $1.0M | 59.9Kdirect | Aug 13, 2018 | Aug 15, 2018 | Form 4 ↗ |
| ROBIN HOWARD WPresident & CEO · Director | Sale | −43.3K | $47.39 | $2.1M | 224.4Kdirect | Jun 27, 2018 | Jun 27, 2018 | Form 4 ↗ |
| ROBIN HOWARD WPresident & CEO · Director | Sale | −43.3K | $49.36 | $2.1M | 224.4Kdirect | Jun 26, 2018 | Jun 27, 2018 | Form 4 ↗ |
| ROBIN HOWARD WPresident & CEO · Director | Sale | −43.3K | $51.82 | $2.2M | 224.4Kdirect | Jun 25, 2018 | Jun 27, 2018 | Form 4 ↗ |
| WHITFIELD ROY ADirector | Purchase | +1,400 | $59.80 | $84K | 177.0Kdirect | Jun 6, 2018 | Jun 7, 2018 | Form 4 ↗ |
| WHITFIELD ROY ADirector | Purchase | +2,000 | $59.07 | $118K | 175.6Kdirect | Jun 6, 2018 | Jun 7, 2018 | Form 4 ↗ |
| GREER R SCOTTDirector | Sale | −8,600 | $60.00 | $516K | 130.3Kdirect | Jun 6, 2018 | Jun 6, 2018 | Form 4 ↗ |
| WHITFIELD ROY ADirector | Purchase | +1,600 | $55.22 | $88K | 173.6Kdirect | Jun 5, 2018 | Jun 7, 2018 | Form 4 ↗ |
| CHESS ROBERTDirector | Sale | −10.0K | $55.16 | $552K | 274.2Kdirect | Jun 5, 2018 | Jun 7, 2018 | Form 4 ↗ |
| GREER R SCOTTDirector | Sale | −1,400 | $61.99 | $87K | 130.3Kdirect | Jun 4, 2018 | Jun 6, 2018 | Form 4 ↗ |
| Thomsen Jillian B.SVP & Chief Accounting Officer | Sale | −3,576 | $83.39 | $298K | 65.3Kdirect | May 16, 2018 | May 18, 2018 | Form 4 ↗ |
| ROBIN HOWARD WPresident & CEO · Director | Sale | −12.8K | $83.39 | $1.1M | 224.4Kdirect | May 16, 2018 | May 18, 2018 | Form 4 ↗ |
| Nicholson JohnSVP & Chief Operating Officer | Sale | −4,917 | $83.39 | $410K | 162.6Kdirect | May 16, 2018 | May 18, 2018 | Form 4 ↗ |
| Labrucherie Gil MSVP & Chief Financial Officer | Sale | −4,941 | $83.39 | $412K | 94.8Kdirect | May 16, 2018 | May 18, 2018 | Form 4 ↗ |
| Hora ManinderSVP Pharma Dev & Mfg Ops | Sale | −4,060 | $83.39 | $339K | 76.2Kdirect | May 16, 2018 | May 18, 2018 | Form 4 ↗ |
| Doberstein Stephen KSVP & Chief Scientific Officer | Sale | −3,435 | $83.39 | $286K | 64.0Kdirect | May 16, 2018 | May 18, 2018 | Form 4 ↗ |
| CHESS ROBERTDirector | Sale | −15.0K | $82.81 | $1.2M | 274.2Kdirect | May 3, 2018 | May 4, 2018 | Form 4 ↗ |
| CHESS ROBERTDirector | Sale | −10.0K | $82.79 | $828K | 274.2Kdirect | May 3, 2018 | May 4, 2018 | Form 4 ↗ |
| Labrucherie Gil MSVP & Chief Financial Officer | Sale | −30.0K | $82.86 | $2.5M | 99.7Kdirect | May 3, 2018 | May 3, 2018 | Form 4 ↗ |
| ROBIN HOWARD WPresident & CEO · Director | Sale | −43.3K | $82.86 | $3.6M | 237.1Kdirect | May 3, 2018 | May 3, 2018 | Form 4 ↗ |
| Labrucherie Gil MSVP & Chief Financial Officer | Sale | −30.0K | $85.63 | $2.6M | 99.7Kdirect | May 2, 2018 | May 3, 2018 | Form 4 ↗ |
| ROBIN HOWARD WPresident & CEO · Director | Sale | −43.3K | $85.63 | $3.7M | 237.1Kdirect | May 2, 2018 | May 3, 2018 | Form 4 ↗ |
| Labrucherie Gil MSVP & Chief Financial Officer | Sale | −30.0K | $83.65 | $2.5M | 99.7Kdirect | May 1, 2018 | May 3, 2018 | Form 4 ↗ |
| ROBIN HOWARD WPresident & CEO · Director | Sale | −43.3K | $83.65 | $3.6M | 237.1Kdirect | May 1, 2018 | May 3, 2018 | Form 4 ↗ |
| Thomsen Jillian B.SVP & Chief Accounting Officer | Sale | −13.9K | $101.46 | $1.4M | 68.9Kdirect | Apr 16, 2018 | Apr 18, 2018 | Form 4 ↗ |
| Hora ManinderSVP Pharma Dev & Mfg Ops | Sale | −502 | $105.67 | $53K | 80.3Kdirect | Apr 10, 2018 | Apr 12, 2018 | Form 4 ↗ |
| Hora ManinderSVP Pharma Dev & Mfg Ops | Sale | −9,498 | $105.05 | $998K | 80.3Kdirect | Apr 9, 2018 | Apr 9, 2018 | Form 4 ↗ |
| Doberstein Stephen KSVP & Chief Scientific Officer | Sale | −49.5K | $96.13 | $4.8M | 67.4Kdirect | Apr 9, 2018 | Apr 9, 2018 | Form 4 ↗ |
| GREER R SCOTTDirector | Sale | −30.0K | $92.22 | $2.8M | 130.3Kdirect | Apr 6, 2018 | Apr 9, 2018 | Form 4 ↗ |
| Doberstein Stephen KSVP & Chief Scientific Officer | Sale | −110.5K | $91.69 | $10.1M | 67.4Kdirect | Apr 6, 2018 | Apr 9, 2018 | Form 4 ↗ |
| CHESS ROBERTDirector | Sale | −15.0K | $92.14 | $1.4M | 274.2Kdirect | Apr 6, 2018 | Apr 9, 2018 | Form 4 ↗ |
| CHESS ROBERTDirector | Sale | −10.0K | $92.15 | $922K | 274.2Kdirect | Apr 6, 2018 | Apr 9, 2018 | Form 4 ↗ |
| Lingnau LutzDirector | Sale | −30.0K | $101.74 | $3.1M | 27.4Kdirect | Apr 5, 2018 | Apr 9, 2018 | Form 4 ↗ |
| Hora ManinderSVP Pharma Dev & Mfg Ops | Sale | −20.0K | $101.75 | $2.0M | 80.3Kdirect | Apr 5, 2018 | Apr 9, 2018 | Form 4 ↗ |
| KUEBLER CHRISTOPHER ADirector | Sale | −37.4K | $97.41 | $3.6M | 40.5Kdirect | Mar 7, 2018 | Mar 8, 2018 | Form 4 ↗ |
| Nicholson JohnSVP & Chief Operating Officer | Sale | −100.1K | $100.45 | $10.1M | 167.5Kdirect | Mar 7, 2018 | Mar 8, 2018 | Form 4 ↗ |
| KUEBLER CHRISTOPHER ADirector | Sale | −2,600 | $100.30 | $261K | 40.5Kdirect | Mar 6, 2018 | Mar 8, 2018 | Form 4 ↗ |
| Nicholson JohnSVP & Chief Operating Officer | Sale | −120.0K | $98.29 | $11.8M | 267.7Kdirect | Mar 6, 2018 | Mar 8, 2018 | Form 4 ↗ |
| Thomsen Jillian B.SVP & Chief Accounting Officer | Sale | −2,545 | $82.94 | $211K | 68.9Kdirect | Feb 16, 2018 | Feb 20, 2018 | Form 4 ↗ |
| ROBIN HOWARD WPresident & CEO · Director | Sale | −12.8K | $82.94 | $1.1M | 237.1Kdirect | Feb 16, 2018 | Feb 20, 2018 | Form 4 ↗ |
| Nicholson JohnSVP & Chief Operating Officer | Sale | −4,879 | $82.94 | $405K | 387.7Kdirect | Feb 16, 2018 | Feb 20, 2018 | Form 4 ↗ |
| Labrucherie Gil MSVP & Chief Financial Officer | Sale | −3,477 | $82.94 | $288K | 99.7Kdirect | Feb 16, 2018 | Feb 20, 2018 | Form 4 ↗ |
| Hora ManinderSVP Pharma Dev & Mfg Ops | Sale | −2,875 | $82.94 | $238K | 80.3Kdirect | Feb 16, 2018 | Feb 20, 2018 | Form 4 ↗ |
| Doberstein Stephen KSVP & Chief Scientific Officer | Sale | −2,426 | $82.94 | $201K | 67.4Kdirect | Feb 16, 2018 | Feb 20, 2018 | Form 4 ↗ |
| ROBIN HOWARD WPresident & CEO · Director | Sale | −83.3K | $75.82 | $6.3M | 249.9Kdirect | Jan 22, 2018 | Jan 24, 2018 | Form 4 ↗ |
| KUEBLER CHRISTOPHER ADirector | Sale | −30.0K | $58.66 | $1.8M | 40.5Kdirect | Jan 2, 2018 | Jan 4, 2018 | Form 4 ↗ |
| ROBIN HOWARD WPresident & CEO · Director | Sale | −83.3K | $55.69 | $4.6M | 189.4Kdirect | Dec 13, 2017 | Dec 15, 2017 | Form 4 ↗ |
| Nicholson JohnSVP & Chief Operating Officer | Sale | −15.9K | $37.78 | $601K | 233.2Kdirect | Nov 13, 2017 | Nov 15, 2017 | Form 4 ↗ |
| Doberstein Stephen KSVP & Chief Scientific Officer | Sale | −300.0K | $30.09 | $9.0M | 31.1Kdirect | Nov 8, 2017 | Nov 8, 2017 | Form 4 ↗ |
| Doberstein Stephen KSVP & Chief Scientific Officer | Sale | −75.4K | $25.78 | $1.9M | 31.1Kdirect | Nov 7, 2017 | Nov 8, 2017 | Form 4 ↗ |
Source: SEC EDGAR Form 4 and Form 5 filings, SEC's quarterly bulk dataset through Jun 30, 2026, and KeyVex's half-hourly read of new filings since. Every row links its filing. Amendments are marked. Nothing here is a recommendation. All insider activity, market-wide →